These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6028880)

  • 1. Cardiovascular effects of prostaglandin E1.
    Nakano J; McCurdy JR
    J Pharmacol Exp Ther; 1967 Jun; 156(3):538-47. PubMed ID: 6028880
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular effects of prostaglandins infused into extra-cranial arteries of the dog.
    Lavery H; Lowe RD; Scroop GC
    J Physiol; 1969 Oct; 204(2):109P+. PubMed ID: 5824619
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of prostaglandin E1 on blood pressure and heart rate in the dog. Prostaglandin and related factors 48.
    Carlson LA; Orö L
    Acta Physiol Scand; 1966 May; 67(1):89-99. PubMed ID: 4381452
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemodynamic effects of prostaglandins (a review of the literature)].
    Muratov VK; Ismailov ShI
    Farmakol Toksikol; 1979; 42(3):303-10. PubMed ID: 376341
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: The cardiovascular effects of sodium pentobarbital anesthesia.
    Ueno A; Nonaka K
    Jpn J Pharmacol; 1974; 24(0):s:72. PubMed ID: 4545625
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of disodium EDTA on the cardiovascular responses to prostaglandin E1.
    Nakano J; Cole B; Ishi T
    Experientia; 1968 Aug; 24(8):808-9. PubMed ID: 4971619
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of the blocking of the beta adrenergic receptors on hemodynamic reactions induced by changes of posture].
    Granata L; Pasquè A; Caraffa Braga E; Data PG
    Boll Soc Ital Biol Sper; 1968 Oct; 44(20):1653-6. PubMed ID: 5720239
    [No Abstract]   [Full Text] [Related]  

  • 8. Sites of action of prostaglandins on the cardiovascular system with particllar reference to the sheep.
    Jones RL
    Acta Biol Med Ger; 1976; 35(8-9):1091-6. PubMed ID: 1007756
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular and metabolic response to infusions of prostaglandin E1 and to simultaneous infusions of noradrenaline and prostaglandin E1 in man. Prostaglandin and related factors 35.
    Bergström S; Carlson LA; Ekelund LG; Orö L
    Acta Physiol Scand; 1965 Aug; 64(4):332-9. PubMed ID: 5853023
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of prostaglandin E1 on the cardiovascular system].
    Suzuki T; Abiko Y; Funaki T
    Nihon Yakurigaku Zasshi; 1969 Mar; 65(2):1-6. PubMed ID: 5387674
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular hyporesponsiveness to norepinephrine, propranolol and nitroglycerin in portal-hypertensive and aged rats.
    Polio J; Sieber CC; Lerner E; Groszmann RJ
    Hepatology; 1993 Jul; 18(1):128-36. PubMed ID: 8325604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of the chronotropic effects of prostacyclin in the dog: comparison with the actions of prostaglandin E2.
    Chiba S; Malik KU
    J Pharmacol Exp Ther; 1980 May; 213(2):261-6. PubMed ID: 6988574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular actions of iproveratril.
    Ross G; Jorgensen CR
    J Pharmacol Exp Ther; 1967 Dec; 158(3):504-9. PubMed ID: 6073232
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral modulation of the cardiovascular effects of l-norepinephrine in the squirrel monkey.
    Kelleher RT; Morse WH; Goldberg SR; Herd JA
    J Pharmacol Exp Ther; 1974 Nov; 191(2):269-83. PubMed ID: 4371767
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of sympathomimetic effects on the cardiovascular system by 4-(2-isopropylamino-1-hydroxyethyl)methanesulfonanilide hydrochloride (MJ 1999).
    Aramendía P; Kaumann AJ
    J Pharmacol Exp Ther; 1967 Feb; 155(2):259-66. PubMed ID: 6025517
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosol administration of prostaglandins E 1 and E 2 and isoproterenol: studies on the cardiovascular system.
    Wendt RL; Baum T
    Eur J Pharmacol; 1972 Jan; 17(1):141-51. PubMed ID: 5016573
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of activators and inhibitors of the kallikrein-kinin system on adrenergic responses of the heart and vessels].
    Rzaev NM; Abaskulieva LI; Khanumova TA; Akhverdiev TG
    Fiziol Zh SSSR Im I M Sechenova; 1977 Mar; 63(3):429-33. PubMed ID: 301104
    [No Abstract]   [Full Text] [Related]  

  • 19. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG; Wang HH
    J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
    [No Abstract]   [Full Text] [Related]  

  • 20. Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man.
    Warrington SJ; Smith PR; O'Grady J
    Eur J Cardiol; 1980; 12(2):73-80. PubMed ID: 7002563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.